Hydrolyzed Formula for Every Infant?

Area of Science:

• Pediatrics
• Nutrition Science
• Allergy Research

Background:

• Hydrolyzed formulas (HF) are used for specific infant populations, including those with cow's milk allergy and for allergy prevention.
• There is increasing global use of HF, raising questions about their suitability for all standard-risk infants not exclusively breastfed.

Purpose of the Study:

• To evaluate the current evidence regarding the nutritional adequacy and long-term growth outcomes of modern hydrolyzed formulas (HF) compared to intact protein formulas (IPF).
• To assess the available data on the efficacy of HF in preventing atopic dermatitis (AD) and compare it with breastfeeding and IPF.
• To determine if HF can be recommended as an optimal choice for all standard-risk, full-term, non-exclusively breastfed infants.

Main Methods:

• Systematic review of existing literature and meta-analyses on formula consumption and infant health outcomes.
• Analysis of data on nutritional adequacy and growth patterns in infants fed HF versus IPF.
• Consideration of cost-effectiveness and limitations of current studies.

Main Results:

• Limited long-term data exists on the growth of infants fed HF compared to IPF.
• Meta-analyses suggest a potential lower risk of atopic dermatitis (AD) with partially hydrolyzed formulas (pHF) versus IPF, but with significant study limitations.
• Cost comparisons of HF globally are difficult due to price variations.

Conclusions:

• Current scientific evidence does not support the routine use of HF as an equivalent option to breastfeeding or IPF for all healthy, standard-risk infants.
• More long-term studies are required to investigate the feasibility and benefits of HF as a routine feeding option.
• Recommendations for widespread HF use must be carefully balanced against the limited available data and potential overstatement of benefits.